Director, Investor Relations

Vericel® Corporation•Burlington, MA
•$180,000 - $230,000•Hybrid

About The Position

The Director, Investor Relations will execute Vericel Corporation’s investor relations program and manage day-to-day engagement with the investment community. Reporting to the Vice President of Finance and Investor Relations, this person will develop investor communications, manage investor relations activities, and build relationships with institutional investors and sell-side research analysts. The Director will collaborate with the Vice President of Finance and Investor Relations, Chief Financial Officer, Chief Executive Officer, and teams across Finance, Commercial, Medical, Legal, and other functions. The role translates Vericel’s financial performance, commercial strategy, clinical data, and long-term growth opportunities into clear investor communications. Key activities include quarterly earnings, investor conferences and meetings, investor targeting, competitive and market analysis, and assessing investor perceptions and expectations. The position is based at Vericel’s Burlington, Massachusetts location. It is onsite Monday through Thursday, with the option to work remotely on Fridays. Travel for investor conferences, roadshows, and other meetings is required. The anticipated annual base salary range is $180,000–$230,000. The role is also eligible for an annual bonus, equity awards, and a comprehensive benefits package, subject to applicable plan terms.

Requirements

  • Bachelor’s degree, preferably in Finance, Accounting, Economics, Business, Life Sciences, or a related discipline.
  • At least 8 years of relevant professional experience in investor relations, equity research, investment banking, investment management, corporate finance, or a related capital markets role.
  • Experience engaging with institutional investors, research analysts, corporate management teams, or investor relations professionals.
  • Experience working with publicly traded companies and a strong understanding of institutional investors’ and sell-side analysts’ expectations.
  • Demonstrated experience developing investor communications, such as earnings materials, corporate presentations, research reports, investment recommendations, or transaction materials.
  • Strong understanding of financial statements, financial modeling, valuation methodologies, and capital markets.
  • Experience analyzing sell-side models, consensus estimates, shareholder data, and peer-company performance.
  • Working knowledge of SEC disclosure requirements, Regulation FD, and public company communications practices.
  • Experience working with senior executives and preparing them for investor and analyst interactions, or evaluating companies through interactions with management and investor relations teams.
  • Excellent written and verbal communication skills, including the ability to explain complex financial, commercial, clinical, and strategic information clearly.
  • Strong financial and analytical capabilities and attention to detail.
  • Strong presentation skills and the judgment and professionalism to represent Vericel with external stakeholders.
  • Strategic thinking and the ability to execute at a detailed level.
  • Understanding of how institutional investors evaluate companies, including financial performance, competitive positioning, valuation, and long-term growth opportunities.
  • Ability to quickly develop expertise in Vericel’s products, markets, clinical data, commercial strategy, and competitive environment.
  • Ability to synthesize financial, market, and competitive information and identify issues relevant to investors and management.
  • Collaborative approach and ability to build relationships across Finance, Commercial, Medical, Legal, and executive leadership.
  • Strong organizational and project-management skills, including managing multiple high-priority initiatives under tight deadlines.
  • Integrity, discretion, and sound judgment when handling confidential and market-sensitive information.
  • Advanced proficiency with Microsoft PowerPoint and Excel.
  • Ability and willingness to travel for investor conferences, non-deal roadshows, and other investor meetings.

Nice To Haves

  • MBA, CFA, or another advanced degree.
  • Healthcare, medical technology, biotechnology, or life sciences experience is strongly preferred.

Responsibilities

  • Partner with the Vice President of Finance and Investor Relations to execute the investor relations strategy, annual engagement plan, and key investor messaging.
  • Develop a deep understanding of Vericel’s business, products, markets, commercial performance, clinical programs, competitive landscape, and strategic objectives.
  • Support development and refinement of the company’s investment narrative and identify opportunities for additional investor education.
  • Help maintain consistent messaging across earnings materials, investor presentations, SEC filings, press releases, investor meetings, and other external communications.
  • Manage key aspects of the quarterly earnings process with the Vice President of Finance and Investor Relations, CFO, and CEO.
  • Draft earnings call scripts, earnings presentations, management Q&A materials, investor talking points, and related materials.
  • Work with Finance and FP&A to understand financial performance, forecasts, business drivers, and trends and communicate them clearly to investors.
  • Partner with Legal, Finance, and other stakeholders to help ensure investor communications are accurate, consistent, and compliant with SEC requirements, Regulation FD, and company disclosure policies.
  • Support preparation of investor-related materials and market updates for executive leadership and the Board of Directors.
  • Serve as a day-to-day contact for institutional investors, sell-side research analysts, and other members of the investment community.
  • Develop and maintain relationships with existing shareholders, prospective investors, and research analysts covering Vericel and the broader healthcare sector.
  • Participate in investor meetings and communicate the company’s strategy, financial performance, and investment proposition in coordination with the Vice President of Finance and Investor Relations.
  • Prepare executives for investor conferences, non-deal roadshows, one-on-one investor meetings, and other external engagements.
  • Participate in investor conferences, roadshows, headquarters meetings, investor calls, and other investor engagement activities.
  • Support investor targeting to identify and build relationships with prospective long-term shareholders.
  • Coordinate with external investor relations advisors, investment banks, and other service providers.
  • Monitor the shareholder base, trading activity, institutional ownership, and investor engagement trends.
  • Gather and synthesize investor and analyst feedback for the Vice President of Finance and Investor Relations and executive management.
  • Maintain an understanding of sell-side research, consensus estimates, valuation methodologies, and financial models used to evaluate Vericel.
  • Monitor relevant medical technology, biotechnology, and healthcare peers’ financial performance, valuation, investor messaging, and strategic developments.
  • Assess capital markets and healthcare sector trends and summarize potential implications for Vericel.
  • Analyze changes in Vericel’s valuation, shareholder composition, and relative stock performance.
  • Identify emerging investor themes and recommend areas for additional investor communication.
  • Support development and maintenance of the corporate investor presentation and other investor-facing materials.
  • Support planning and execution of investor days, analyst events, facility visits, and other strategic investor communications initiatives.
  • Collaborate with internal teams on investor communications related to significant clinical, regulatory, commercial, or corporate developments.
  • Support maintenance and enhancement of the investor relations website and associated resources.
  • Identify opportunities to improve investor communications and engagement using investor feedback, engagement analytics, and industry best practices.

Benefits

  • Annual bonus eligibility
  • Equity awards
  • Comprehensive benefits package
  • Mission-driven work
  • Career growth opportunities
  • Collaborative culture
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service